Bausch & Lomb Corp (BLCO) revenue by segment
BLCONYSEOphthalmic GoodsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 9/3028% below fair value
$20.95+0.12 (+0.58%)
Close on Nov 18, 2026Market cap $7.49BP/E –Yield –
Doanh thu theo bộ phận của Bausch & Lomb Corp
Theo bộ phận kinh doanh
| Doanh thu | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|
| Vision Care | $2.92B | $2.74B | $2.54B | $2.37B | $2.33B | $2.11B | 57.3% | +6.7% |
| Pharmaceuticals | $1.28B | $1.21B | $836.00M | $681.00M | $720.00M | – | 25.2% | +6.2% |
| Surgical | $894.00M | $843.00M | $767.00M | $718.00M | $718.00M | $577.00M | 17.5% | +6.0% |
| Ophthalmic Pharmaceuticals | – | – | – | $677.00M | $704.00M | $726.00M | – | – |
| Lợi nhuận hoạt động | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | YoY |
|---|---|---|---|---|---|---|---|
| Vision Care | $849.00M | $808.00M | $689.00M | $636.00M | $576.00M | $579.00M | +5.1% |
| Pharmaceuticals | $258.00M | $256.00M | $241.00M | $203.00M | $301.00M | – | +0.8% |
| Surgical | $18.00M | $44.00M | $50.00M | $42.00M | $75.00M | $18.00M | -59.1% |
| Ophthalmic Pharmaceuticals | – | – | – | $202.00M | $290.00M | $302.00M | – |
Theo sản phẩm hoặc dịch vụ
| Doanh thu | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|
| Product sales | $5.08B | $4.77B | $4.13B | $3.75B | $3.74B | $3.38B | 99.6% | +6.4% |
| Devices | $1.92B | $1.80B | $1.65B | $1.57B | $1.60B | $1.31B | 37.7% | +6.8% |
| OTC | $1.83B | $1.72B | $1.61B | $1.46B | $1.39B | $1.31B | 36.0% | +6.4% |
| Pharmaceuticals | $1.08B | $969.00M | $618.00M | $468.00M | $493.00M | $508.00M | 21.2% | +11.6% |
| Branded and Other Generics | $243.00M | $281.00M | $252.00M | $245.00M | $254.00M | $249.00M | 4.8% | -13.5% |
| Other revenues | $21.00M | $17.00M | $15.00M | $22.00M | $28.00M | $31.00M | 0.4% | +23.5% |
Theo khu vực
| Doanh thu | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|
| U.S. and Puerto Rico | $2.55B | $2.41B | $1.93B | $1.70B | $1.62B | $1.56B | 49.9% | +5.5% |
| Other | $777.00M | $712.00M | $655.00M | $616.00M | $572.00M | $516.00M | 15.2% | +9.1% |
| China | $358.00M | $358.00M | $344.00M | $343.00M | $390.00M | $280.00M | 7.0% | 0.0% |
| France | $246.00M | $227.00M | $210.00M | $195.00M | $201.00M | $174.00M | 4.8% | +8.4% |
| Japan | $186.00M | $180.00M | $187.00M | $192.00M | $224.00M | $220.00M | 3.6% | +3.3% |
| Germany | $164.00M | $152.00M | $147.00M | $138.00M | $149.00M | $137.00M | 3.2% | +7.9% |
| Russia | $148.00M | $120.00M | $106.00M | $132.00M | $116.00M | $102.00M | 2.9% | +23.3% |
| United Kingdom | $137.00M | $132.00M | $121.00M | $108.00M | $111.00M | $84.00M | 2.7% | +3.8% |
| Canada | $135.00M | $127.00M | $110.00M | $101.00M | $101.00M | $92.00M | 2.6% | +6.3% |
| Italy | $102.00M | $91.00M | $82.00M | $72.00M | $75.00M | $67.00M | 2.0% | +12.1% |
| Spain | $101.00M | $92.00M | $85.00M | $77.00M | $80.00M | $66.00M | 2.0% | +9.8% |
| Poland | $75.00M | $65.00M | $51.00M | $44.00M | $42.00M | $36.00M | 1.5% | +15.4% |
| Mexico | $75.00M | $75.00M | $68.00M | $55.00M | $40.00M | $32.00M | 1.5% | 0.0% |
| South Korea | $51.00M | $47.00M | $46.00M | $44.00M | $46.00M | $48.00M | 1.0% | +8.5% |
| Belarus | – | – | – | $8.00M | $7.00M | $8.00M | – | – |
| Ukraine | – | – | – | $7.00M | $12.00M | $14.00M | – | – |
Lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K, 10-Q của Bausch & Lomb (XBRL). Số quý 4 bằng cả năm tài chính trừ chín tháng đầu. Tên bộ phận giữ theo cách công ty tự đặt và có thể đổi khi công ty tái cấu trúc. Tab KPI hiện các bộ phận này cạnh chỉ số vận hành của Bausch & Lomb, kèm đầy đủ lịch sử, biểu đồ và liên kết tới từng hồ sơ.
See a number that looks wrong?